Lidocaine Hydrochloride Monohydrate

• CAT Number: R009735
• CAS Number: 6108-05-0
• Molecular Formula: C14H25ClN2O2
• Molecular Weight: 288.816
• Purity: ≥95%
• Synonyms: 2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide Hydrochloride Monohydrate; Basicaina Monohydrate; Batixim Monohydrate; Dynexan Monohydrate; Heweneural Monohydrate; Licain Monohydrate
• Storage: -20°C
• IUPAC Name: 2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrate;hydrochloride
• InChI: InChI=1S/C14H22N2O.ClH.H2O/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4;;/h7-9H,5-6,10H2,1-4H3,(H,15,17);1H;1H2
• InChIKey: YECIFGHRMFEPJK-UHFFFAOYSA-N
• SMILES: CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.O.Cl

Lidocaine Hydrochloride Monohydrate is a widely used local anesthetic and antiarrhythmic agent in medical and pharmaceutical research. Known for its effectiveness in numbing tissue and treating irregular heartbeats, it is essential for studying pain management, anesthesia mechanisms, and cardiac arrhythmias. This compound aids in developing new therapeutic formulations and understanding drug action. Researchers and clinicians rely on Lidocaine Hydrochloride Monohydrate for precise and reliable results in advanced medical research, contributing significantly to innovations in pain relief and cardiovascular treatment.